Member Exclusive

Genetically modified human umbilical cells could be a treatment for spinal cord injuries

Genetically modified human umbilical cord blood mononuclear cells have been shown to increase the number of Schwann cells in a murine model with spinal cord injuries. The results could lead to regenerative medicines for spinal cord injuries.

Go to the profile of Adam Tarring
Jul 09, 2018

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.


No comments yet.